导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.21% | 771/1050 |
| 近一周 | -4.23% | 1055/1104 |
| 近一月 | -2.44% | 429/1103 |
| 近一季 | -3.61% | 411/1092 |
| 近半年 | -15.36% | 915/1070 |
| 近一年 | -7.17% | 710/1018 |
| 近两年 | 36.49% | 627/926 |
| 近三年 | 6.19% | 619/834 |
| 成立以来 | 146.26% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.81% 424/1070 |
-10.68% 928/1101 |
- - |
- - |
| 2025 | 16.00% 736/1065 |
2.49% 606/1014 |
-0.87% 753/1038 |
14.66% 747/1050 |
-0.42% 481/1065 |
| 2024 | 10.02% 289/1011 |
-1.22% 383/960 |
0.87% 249/983 |
11.64% 488/991 |
-1.09% 389/1011 |
| 2023 | -4.34% 188/952 |
6.14% 247/880 |
-0.85% 233/895 |
0.52% 74/915 |
-9.58% 841/952 |
| 2022 | -5.89% 39/867 |
-5.68% 39/773 |
6.74% 424/806 |
-11.07% 306/845 |
5.11% 200/867 |
| 2021 | 1.72% 338/740 |
2.36% 84/580 |
-4.98% 574/659 |
-1.26% 238/704 |
5.90% 186/740 |
| 2020 | 39.02% 303/554 |
-4.33% 267/419 |
17.63% 322/466 |
16.52% 118/517 |
6.01% 420/554 |
| 2019 | 40.65% 215/410 |
34.68% 152/1149 |
-6.76% 834/1231 |
1.14% 302/390 |
10.74% 143/410 |
| 2018 | - - |
- - |
- - |
- - |
-2.62% 31/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国联安价值优选股票 VS. 东吴新产业精选股票A(580008) |